Bing Cui

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Nature communications

Nature metabolism

Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Materia Medica

Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Materia Medica (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Materia Medica Sep 01 2015

China

Professor :: State Key Laboratory of Bioactive Substance and Function of Natural Medicines

University of California San Diego Dec 01 2012 - Aug 30 2015

United States

Assistant Project Scientist :: Division of Hematology-Oncology, Moores Cancer Center

Education History

Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Materia Medica Sep 01 2004 - Jun 30 2007

China

PHD :: Molecular Pharmacology

China Pharmaceutical University Sep 01 2001 - Jun 30 2004

China

MSC :: Cardiovascular Pharmacology

China Pharmaceutical University Sep 01 1996 - Jun 30 2001

China

BSC :: Pharmacology

Publications

Feng Wang, Yunxuan Li, Zhaona Yang, Wenbin Cao, Ying Liu, Luyao Zhao, Tingting Zhang, Chenxi Zhao, Jin-Mei Yu, Jiaojiao Yu, Jichao Zhou, Xiao-Wei Zhang, Ping-Ping Li, Mingzhe Han, Sizhou Feng, Billy Wai-Lung Ng, Zhuo-Wei Hu, Erlie Jiang, Ke Li, Bing Cui
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Nature communications 15 (1) (2024)
Feng Wang, Yunxuan Li, Zhaona Yang, Wenbin Cao, Ying Liu, Luyao Zhao, Tingting Zhang, Chenxi Zhao, Jin-Mei Yu, Jiaojiao Yu, Jichao Zhou, Xiao-Wei Zhang, Ping-Ping Li, Mingzhe Han, Sizhou Feng, Billy Wai-Lung Ng, Zhuo-Wei Hu, Erlie Jiang, Ke Li, Bing Cui
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Nature communications 15 (1) (2024)
Qian Jiang, Qijin Zhao, Yibing Chen, Chunxiao Ma, Xiaohong Peng, Xi Wu, Xing-Feng Liu, Ruoran Wang, Shaocong Hou, Lijuan Kong, Yanjun Wan, Shu-Sen Wang, Zhuo-Xian Meng, Bing Cui, Liangyi Chen, Ping-Ping Li
Galectin-3 impairs calcium transients and β-cell function. Nature communications 15 (1) (2024)
Qian Jiang, Qijin Zhao, Yibing Chen, Chunxiao Ma, Xiaohong Peng, Xi Wu, Xing-Feng Liu, Ruoran Wang, Shaocong Hou, Lijuan Kong, Yanjun Wan, Shu-Sen Wang, Zhuo-Xian Meng, Bing Cui, Liangyi Chen, Ping-Ping Li
Galectin-3 impairs calcium transients and β-cell function. Nature communications 15 (1) (2024)
Feng Wang, Yunxuan Li, Zhaona Yang, Wenbin Cao, Ying Liu, Luyao Zhao, Tingting Zhang, Chenxi Zhao, Jin-Mei Yu, Jiaojiao Yu, Jichao Zhou, Xiao-Wei Zhang, Ping-Ping Li, Mingzhe Han, Sizhou Feng, Billy Wai-Lung Ng, Zhuo-Wei Hu, Erlie Jiang, Ke Li, Bing Cui
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Nature communications 15 (1) (2024)
Lijuan Kong, Qijin Zhao, Xiaojing Jiang, Jinping Hu, Qian Jiang, Li Sheng, Xiaohong Peng, Shu-Sen Wang, Yibing Chen, Yanjun Wan, Shaocong Hou, Xing-Feng Liu, Chunxiao Ma, Yan Li, Li Quan, Liangyi Chen, Bing Cui, Ping-Ping Li
Trimethylamine N-oxide impairs β-cell function and glucose tolerance. Nature communications 15 (1) (2024)
Qian Jiang, Qijin Zhao, Yibing Chen, Chunxiao Ma, Xiaohong Peng, Xi Wu, Xing-Feng Liu, Ruoran Wang, Shaocong Hou, Lijuan Kong, Yanjun Wan, Shu-Sen Wang, Zhuo-Xian Meng, Bing Cui, Liangyi Chen, Ping-Ping Li
Galectin-3 impairs calcium transients and β-cell function. Nature communications 15 (1) (2024)
Lijuan Kong, Qijin Zhao, Xiaojing Jiang, Jinping Hu, Qian Jiang, Li Sheng, Xiaohong Peng, Shu-Sen Wang, Yibing Chen, Yanjun Wan, Shaocong Hou, Xing-Feng Liu, Chunxiao Ma, Yan Li, Li Quan, Liangyi Chen, Bing Cui, Ping-Ping Li
Trimethylamine N-oxide impairs β-cell function and glucose tolerance. Nature communications 15 (1) (2024)
Lijuan Kong, Qijin Zhao, Xiaojing Jiang, Jinping Hu, Qian Jiang, Li Sheng, Xiaohong Peng, Shu-Sen Wang, Yibing Chen, Yanjun Wan, Shaocong Hou, Xing-Feng Liu, Chunxiao Ma, Yan Li, Li Quan, Liangyi Chen, Bing Cui, Ping-Ping Li
Trimethylamine N-oxide impairs β-cell function and glucose tolerance. Nature communications 15 (1) (2024)
Qian Jiang, Qijin Zhao, Yibing Chen, Chunxiao Ma, Xiaohong Peng, Xi Wu, Xing-Feng Liu, Ruoran Wang, Shaocong Hou, Lijuan Kong, Yanjun Wan, Shu-Sen Wang, Zhuo-Xian Meng, Bing Cui, Liangyi Chen, Ping-Ping Li
Galectin-3 impairs calcium transients and β-cell function. Nature communications 15 (1) (2024)
Qian Jiang, Qijin Zhao, Yibing Chen, Chunxiao Ma, Xiaohong Peng, Xi Wu, Xing-Feng Liu, Ruoran Wang, Shaocong Hou, Lijuan Kong, Yanjun Wan, Shu-Sen Wang, Zhuo-Xian Meng, Bing Cui, Liangyi Chen, Ping-Ping Li
Galectin-3 impairs calcium transients and β-cell function. Nature communications 15 (1) (2024)
Feng Wang, Yunxuan Li, Zhaona Yang, Wenbin Cao, Ying Liu, Luyao Zhao, Tingting Zhang, Chenxi Zhao, Jin-Mei Yu, Jiaojiao Yu, Jichao Zhou, Xiao-Wei Zhang, Ping-Ping Li, Mingzhe Han, Sizhou Feng, Billy Wai-Lung Ng, Zhuo-Wei Hu, Erlie Jiang, Ke Li, Bing Cui
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Nature communications 15 (1) (2024)
Shuang Shang, Chen Yang, Fei Chen, Ren-Shen Xiang, Huan Zhang, Shu-Yuan Dai, Jing Liu, Xiao-Xi Lv, Cheng Zhang, Xiao-Tong Liu, Qi Zhang, Shuai-Bing Lu, Jia-Wei Song, Jiao-Jiao Yu, Ji-Chao Zhou, Xiao-Wei Zhang, Bing Cui, Ping-Ping Li, Sheng-Tao Zhu, Hai-Zeng Zhang, Fang Hua
ID1 expressing macrophages support cancer cell stemness and limit CD8 + T cell infiltration in colorectal cancer. Nature communications 14 (1) (2023)
Xingfeng Liu, Kai Wang, Shaocong Hou, Qian Jiang, Chunxiao Ma, Qijin Zhao, Lijuan Kong, Jingwen Chen, Zhenhe Wang, Huabing Zhang, Tao Yuan, Yuxiu Li, Yi Huan, Zhufang Shen, Zhuo-Wei Hu, Zhifeng Huang, Bing Cui, Ping-Ping Li
Insulin induces insulin receptor degradation in the liver through EphB4. Nature metabolism 4 (9) (2022)
Jiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang, Bing Cui, Feng-Wei Tan, Junjian Wang, Ke Li, Shuang Shang, Cheng Zhang, Xiao-Xi Lv, Xiao-Wei Zhang, Shan-Shan Liu, Jin-Mei Yu, Feng Wang, Bo Huang, Fang Hua, Zhuo-Wei Hu
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target. Nature communications 11 (1) (2020)
Ke Li, Feng Wang, Zhao-Na Yang, Ting-Ting Zhang, Yu-Fen Yuan, Chen-Xi Zhao, Zaiwuli Yeerjiang, Bing Cui, Fang Hua, Xiao-Xi Lv, Xiao-Wei Zhang, Jiao-Jiao Yu, Shan-Shan Liu, Jin-Mei Yu, Shuang Shang, Yang Xiao, Zhuo-Wei Hu
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation. Nature communications 11 (1) (2020)
Jin-Mei Yu, Wei Sun, Zhen-He Wang, Xiao Liang, Fang Hua, Ke Li, Xiao-Xi Lv, Xiao-Wei Zhang, Yu-Ying Liu, Jiao-Jiao Yu, Shan-Shan Liu, Shuang Shang, Feng Wang, Zhao-Na Yang, Chen-Xi Zhao, Xue-Ying Hou, Ping-Ping Li, Bo Huang, Bing Cui, Zhuo-Wei Hu
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription. Nature communications 10 (1) (2019)

Bing Cui.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bing Cui